Publications by authors named "Daniel Dexter"

Claim this Profile
I
Indicators of inequity in research and funding for sickle cell disease, cystic fibrosis and haemophilia: a descriptive comparative study.
Rutendo Muzambi, Alex Bottle, Daniel Dexter, Cherelle Augustine, Jeannine Joseph

Lancet Haematol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hydroxyurea for children with sickle cell disease in sub-Saharan Africa: A summary of the evidence, opportunities, and challenges.
Daniel Dexter, Patrick T McGann

Pharmacotherapy· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peripheral blood features of iron overload in post-splenectomy, type I congenital dyserythropoietic anemia.
Daniel Dexter, D Mark Layton, Kripesh Kiritkumar, Barbara J Bain

Am J Hematol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Saving lives through early diagnosis: the promise and role of point of care testing for sickle cell disease.
Daniel Dexter, Patrick T McGann

Br J Haematol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Remdesivir during induction chemotherapy for newly diagnosed paediatric acute lymphoblastic leukaemia with concomitant SARS-CoV-2 infection.
Katharine Orf, Srdan Rogosic, Daniel Dexter, Phil Ancliff, Saket Badle

Br J Haematol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mitigating the effect of the COVID-19 pandemic on sickle cell disease services in African countries.
Daniel Dexter, David Simons, Charles Kiyaga, Nathan Kapata, Francine Ntoumi

Lancet Haematol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fast half-sibling population reconstruction: theory and algorithms.
Daniel Dexter, Daniel G Brown

Algorithms Mol Biol· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical antitumor activity and pharmacokinetics of methyl-2-benzimidazolecarbamate (FB642).
Desirée Hao, Jinee D Rizzo, Stephanie Stringer, Rodney V Moore, Jennifer Marty, Daniel L Dexter

Invest New Drugs· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GEM 231, a second-generation antisense agent complementary to protein kinase A RIalpha subunit, potentiates antitumor activity of irinotecan in human colon, pancreas, prostate and lung cancer xenografts.
Sudhir Agrawal, Ekambar R Kandimalla, Dong Yu, Robin Ball, Gina Lombardi, Daniel L Dexter

Int J Oncol· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis